Swiss National Bank - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$692,000
-13.8%
13,1000.0%0.00%0.0%
Q2 2020$803,000
+35.2%
13,100
+24.8%
0.00%0.0%
Q1 2020$594,000
-0.7%
10,5000.0%0.00%0.0%
Q4 2019$598,000
+9.5%
10,500
+2.9%
0.00%0.0%
Q3 2019$546,000
-10.3%
10,2000.0%0.00%0.0%
Q2 2019$609,000
+0.7%
10,200
+5.2%
0.00%0.0%
Q1 2019$605,000
+2.9%
9,7000.0%0.00%0.0%
Q4 2018$588,0009,7000.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2019
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 36,000$2,244,0002.71%
JW Asset Management, LLC 73,649$4,591,0002.36%
THB ASSET MANAGEMENT 87,491$5,453,0000.79%
RICE HALL JAMES & ASSOCIATES, LLC 315,972$19,695,0000.63%
EAM Global Investors LLC 22,789$1,420,0000.63%
Elk Creek Partners, LLC 73,936$4,608,0000.33%
Matarin Capital Management, LLC 69,964$4,361,0000.32%
EAM Investors, LLC 17,696$1,103,0000.27%
CADENCE CAPITAL MANAGEMENT LLC 37,196$2,318,0000.21%
Cavalier Investments, LLC 7,800$486,0000.20%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders